Definition
Carbinoxamine is a first‑generation antihistamine that acts as an H₁‑receptor antagonist, used primarily to alleviate symptoms of allergic conditions such as rhinitis, urticaria, and conjunctivitis.
Overview
Developed in the 1970s, carbinoxamine is administered orally in tablet or syrup form, often as the maleate salt. It was marketed under various brand names, including Bencard and Alacarb. In many countries it is available by prescription, while in the United States it was withdrawn from over‑the‑counter sale in the early 2000s due to concerns about sedation and anticholinergic side effects. The drug exhibits typical first‑generation antihistamine properties, including central nervous system penetration leading to drowsiness, dry mouth, and impaired coordination.
Etymology / Origin
The name “carbinoxamine” combines elements that describe its chemical structure: “carb‑” refers to a carbamyl (carboxamide) group, “ox” denotes the presence of an oxygen‑containing moiety, and “‑amine” indicates an amine functional group. Accurate information about the precise rationale for the naming by the original manufacturers is not confirmed.
Characteristics
- Chemical classification: Pyridylamine derivative; the active form is carbinoxamine maleate.
- Pharmacodynamics: Competitive blockade of peripheral and central H₁ histamine receptors, reducing vasodilation, edema, and pruritus associated with allergic reactions. It also exhibits weak anticholinergic activity.
- Pharmacokinetics: Well absorbed after oral administration; reaches peak plasma concentrations within 1–2 hours. It is extensively metabolized in the liver, primarily via oxidative pathways, and eliminated mainly in the urine. The elimination half‑life ranges from 5 to 7 hours in healthy adults.
- Therapeutic uses: Relief of symptoms of seasonal and perennial allergic rhinitis, acute urticaria, allergic conjunctivitis, and occasionally as an adjunct in the treatment of asthma‑related bronchospasm.
- Adverse effects: Common side effects include sedation, drowsiness, dry mouth, blurred vision, and urinary retention. Rare but serious reactions may involve paradoxical excitability or hypersensitivity.
- Regulatory status: Prescription‑only in most jurisdictions; withdrawn from the US over‑the‑counter market in 2005.
Related Topics
- First‑generation antihistamines (e.g., diphenhydramine, chlorpheniramine)
- H₁‑receptor antagonists
- Allergic rhinitis and urticaria management
- Anticholinergic side effects of antihistamines
- Drug‑induced sedation and its impact on driving safety
- Pharmacology of histamine and its receptors.